Annual report pursuant to Section 13 and 15(d)

Acquisitions, Investments, and Licenses - Summary of Pro Forma Results (Details)

v2.4.0.8
Acquisitions, Investments, and Licenses - Summary of Pro Forma Results (Details) (Cytochroma and PROLOR [Member], USD $)
In Thousands, except Per Share data, unless otherwise specified
12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Cytochroma and PROLOR [Member]
   
Pro Forma Result of Combined Companies    
Revenues $ 96,530 $ 53,595
Loss from continuing operations 0 (63,479)
Net loss (147,546) (55,663)
Net loss attributable to common shareholders $ (145,027) $ (57,411)
Basic and diluted loss from continuing operations per share $ (0.37) $ (0.15)
Basic and diluted loss from discontinued operations per share $ 0.00 $ 0.00
Basic and diluted loss per share (in dollars per share) $ (0.37) $ (0.15)